[Whitepaper] Optimizing Operations in Multiproduct Pharma Manufacturing Facilities

Facilities flexible enough to manufacture multiple products have become a cornerstone of our industry, crucial for meeting changing and challenging market and regulatory expectations.

But for optimal operation, these facilities require more space and different architecture than traditional pharmaceutical manufacturing plants.

When you are investing in products that can change lives, scrutiny of your prospective CDMO’s plant is key — an antiquated or ill-designed facility adds risk.

This whitepaper covers important features to look for in:

  • Building design
  • Equipment design
  • SUS vs. stainless steel
  • Personnel training and safety
  • Planning and scheduling
  • Regulatory and quality systems

Along with the whitepaper, you’ll receive a detailed checklist.

Sponsored by: